StockMarketWire.com - Animalcare has launched a new product, Vitofyllin, a tablet prescribed for problems associated with canine ageing. Vitofyllin (propentofylline) fits well into Animalcare's growing portfolio of products to treat chronic diseases and conditions of old age in pets.

In this case Vitofyllin is a central nervous system stimulant for older dogs suffering from dullness, poor demeanour and unwillingness to exercise.

It says the market for Vitofyllin in the UK and Ireland is worth approximately £1.5m per annum.


At 8:45am: [LON:ANCR] share price was +0.5p at 125.5p



Story provided by StockMarketWire.com